| Title |
Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial
|
|---|---|
| Published in |
British Medical Journal, October 2019
|
| DOI | 10.1136/bmj.l5654 |
| Pubmed ID | |
| Authors |
Lars Christian Haugli Bråten, Mads Peder Rolfsen, Ansgar Espeland, Monica Wigemyr, Jörg Aßmus, Anne Froholdt, Anne Julsrud Haugen, Gunn Hege Marchand, Per Martin Kristoffersen, Olav Lutro, Sigrun Randen, Maja Wilhelmsen, Bendik Slagsvold Winsvold, Thomas Istvan Kadar, Thor Einar Holmgard, Maria Dehli Vigeland, Nils Vetti, Øystein Petter Nygaard, Benedicte Alexandra Lie, Christian Hellum, Audny Anke, Margreth Grotle, Elina Iordanova Schistad, Jan Sture Skouen, Lars Grøvle, Jens Ivar Brox, John-Anker Zwart, Kjersti Storheim |
X Demographics
The data shown below were collected from the profiles of 547 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 103 | 19% |
| United States | 57 | 10% |
| Australia | 34 | 6% |
| Canada | 27 | 5% |
| Norway | 21 | 4% |
| Netherlands | 11 | 2% |
| France | 9 | 2% |
| Spain | 8 | 1% |
| Germany | 6 | 1% |
| Other | 81 | 15% |
| Unknown | 190 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 353 | 65% |
| Practitioners (doctors, other healthcare professionals) | 105 | 19% |
| Scientists | 81 | 15% |
| Science communicators (journalists, bloggers, editors) | 8 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 181 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 20 | 11% |
| Student > Master | 17 | 9% |
| Other | 14 | 8% |
| Researcher | 14 | 8% |
| Student > Ph. D. Student | 13 | 7% |
| Other | 35 | 19% |
| Unknown | 68 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 28% |
| Nursing and Health Professions | 22 | 12% |
| Neuroscience | 7 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
| Agricultural and Biological Sciences | 3 | 2% |
| Other | 14 | 8% |
| Unknown | 77 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 381. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#78,663
of 24,901,761 outputs
Outputs from British Medical Journal
#1,330
of 63,869 outputs
Outputs of similar age
#1,578
of 360,909 outputs
Outputs of similar age from British Medical Journal
#33
of 866 outputs
Altmetric has tracked 24,901,761 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 63,869 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,909 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 866 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.